Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Liabilities and Shareholders Equity (2016 - 2025)

Surgery Partners' Liabilities and Shareholders Equity history spans 12 years, with the latest figure at $8.1 billion for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 2.91% year-over-year to $8.1 billion; the TTM value through Dec 2025 reached $32.0 billion, up 6.96%, while the annual FY2025 figure was $8.1 billion, 2.91% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $8.1 billion at Surgery Partners, up from $7.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $8.1 billion in Q4 2025 and bottomed at $5.6 billion in Q2 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $6.7 billion (2022), against an average of $6.9 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity increased 16.07% in 2022 before it rose 2.91% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $6.1 billion in 2021, then rose by 9.23% to $6.7 billion in 2022, then increased by 2.91% to $6.9 billion in 2023, then increased by 14.74% to $7.9 billion in 2024, then increased by 2.91% to $8.1 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Liabilities and Shareholders Equity are $8.1 billion (Q4 2025), $7.9 billion (Q3 2025), and $8.0 billion (Q2 2025).